Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Katrin Riemann

1PUBLICATIONS
5CO-AUTHORS
Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|May 14, 2025
GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer's Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation.

Katrin Riemann, Jeldrik von Ahsen, Tamara Böhm

Pageof 1

Frequent Collaborators

1 joint publications

Tamara Böhm

1 joint publications

Martin Schlegel

1 joint publications

Matthias Kreuzer

1 joint publications

Thomas Fenzl

1 joint publications

Gerhard Rammes

Frequent Collaborators

1 joint publications

Tamara Böhm

1 joint publications

Martin Schlegel

1 joint publications

Matthias Kreuzer

1 joint publications

Thomas Fenzl

Top Related Videos

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on : May 13, 2010

19.3K
See more related videos

Top Related Videos

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
15:23

Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease

Published on : May 13, 2010

19.3K
See more related videos